Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study. | ESMO Open | 2022 | 35798468 | PubTator, text mining | PubMed |
| Differences in actionable genomic alterations between brain metastases and non‑brain metastases in patients with non‑small cell lung cancer. | Int J Oncol | 2022 | 35796015 | PubTator, text mining | PubMed |
| Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population. | Front Pharmacol | 2022 | 35784703 | PubTator, text mining | PubMed |
| Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer. | Front Immunol | 2022 | 35784334 | PubTator, text mining | PubMed |
| Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001). | Gastric Cancer | 2022 | 35767198 | PubTator, text mining | PubMed |
| Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective. | Pharmgenomics Pers Med | 2022 | 35761855 | PubTator, text mining | PubMed |
| The Roles of Drug Metabolism-Related ADH1B in Immune Regulation and Therapeutic Response of Ovarian Cancer. | Front Cell Dev Biol | 2022 | 35756990 | PubTator, text mining | PubMed |
| Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials. | Pharmaceutics | 2022 | 35745786 | PubTator, text mining | PubMed |
| Pharmacogenomic Profile of Amazonian Amerindians. | J Pers Med | 2022 | 35743738 | PubTator, text mining | PubMed |
| Genetic Variations of the DPYD Gene and Its Relationship with Ancestry Proportions in Different Ecuadorian Trihybrid Populations. | J Pers Med | 2022 | 35743735 | PubTator, text mining | PubMed |
| Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. | Cancers (Basel) | 2022 | 35740594 | PubTator, text mining | PubMed |
| Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective. | Pathophysiology | 2022 | 35736645 | PubTator, text mining | PubMed |
| Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study. | Croat Med J | 2022 | 35722694 | PubTator, text mining | PubMed |
| Genome-Wide Placental Gene Methylations in Gestational Diabetes Mellitus, Fetal Growth and Metabolic Health Biomarkers in Cord Blood. | Front Endocrinol (Lausanne) | 2022 | 35721735 | PubTator, text mining | PubMed |
| Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality. | Front Endocrinol (Lausanne) | 2022 | 35721730 | PubTator, text mining | PubMed |
| Genome-wide association study of musical beat synchronization demonstrates high polygenicity. | Nat Hum Behav | 2022 | 35710621 | PubTator, text mining | PubMed |
| Evaluation of the Tasso-SST® capillary blood microsampling device for the measurement of endogenous uracil levels. | Clin Biochem | 2022 | 35709975 | PubTator, text mining | PubMed |
| Improving the tolerability of osimertinib by identifying its toxic limit. | Ther Adv Med Oncol | 2022 | 35677320 | PubTator, text mining | PubMed |
| Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer. | Clin Colorectal Cancer | 2022 | 35668003 | PubTator, text mining | PubMed |
| A pilot study of assessing whole genome sequencing in newborn screening in unselected children in China. | Clin Transl Med | 2022 | 35665479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=43